Backpack
    1.
    外观设计
    Backpack 有权

    公开(公告)号:USD851392S1

    公开(公告)日:2019-06-18

    申请号:US29571810

    申请日:2016-07-21

    申请人: Peter Kao

    设计人: Peter Kao

    Backpack with suspension arrangement

    公开(公告)号:US10130161B2

    公开(公告)日:2018-11-20

    申请号:US15076622

    申请日:2016-03-21

    申请人: Peter Kao

    发明人: Peter Kao

    IPC分类号: A45F3/12 A45F3/04

    摘要: A backpack includes a pack body, two length-adjustable shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

    Backpack with suspension arrangement

    公开(公告)号:US09888761B2

    公开(公告)日:2018-02-13

    申请号:US15232772

    申请日:2016-08-09

    申请人: Peter Kao

    发明人: Peter Kao

    IPC分类号: A45F3/04

    CPC分类号: A45F3/047 A45C13/02 A45F3/12

    摘要: A backpack includes a pack body, two shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

    Juice bottle
    5.
    外观设计
    Juice bottle 有权
    果汁瓶

    公开(公告)号:USD577601S1

    公开(公告)日:2008-09-30

    申请号:US29276435

    申请日:2007-01-25

    申请人: Peter Kao

    设计人: Peter Kao

    Implantable arterio-venous shunt devices and methods for their use
    6.
    发明申请
    Implantable arterio-venous shunt devices and methods for their use 有权
    可植入的动静脉分流装置及其使用方法

    公开(公告)号:US20070299384A1

    公开(公告)日:2007-12-27

    申请号:US11789759

    申请日:2007-04-24

    IPC分类号: A61M5/00

    摘要: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

    摘要翻译: 提供长期植入式动静脉分流装置或瘘管的产生,其可用作治疗慢性阻塞性肺病(COPD)的治疗方法。 分流装置植入动脉和静脉之间,优选植入外周动脉和下腔静脉之间。 创建瘘管的分流装置和方法增加心输出量并降低全身血管阻力,并且允许在植入后通过分流装置的血流速度至少为5ml / min。 基于方法和装置对呼吸,心脏和循环系统的影响,该方法和装置作为对与这些系统相关的问题或病症的患者的治疗是有益的。

    IMPLANTABLE ARTERIO-VENOUS SHUNT DEVICES AND METHODS FOR THEIR USE
    7.
    发明申请
    IMPLANTABLE ARTERIO-VENOUS SHUNT DEVICES AND METHODS FOR THEIR USE 有权
    可植入式静脉穿刺装置及其使用方法

    公开(公告)号:US20110270149A1

    公开(公告)日:2011-11-03

    申请号:US13101240

    申请日:2011-05-05

    IPC分类号: A61M1/00

    摘要: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

    摘要翻译: 提供长期植入式动静脉分流装置或瘘管的产生,其可用作治疗慢性阻塞性肺病(COPD)的治疗方法。 分流装置植入动脉和静脉之间,优选植入外周动脉和下腔静脉之间。 创建瘘管的分流装置和方法增加心输出量并降低全身血管阻力,并且允许在植入后通过分流装置的血流速度至少为5ml / min。 基于方法和装置对呼吸,心脏和循环系统的影响,该方法和装置作为对与这些系统相关的问题或病症的患者的治疗是有益的。

    PCI Express-Compatible Controller And Interface For Flash Memory
    8.
    发明申请
    PCI Express-Compatible Controller And Interface For Flash Memory 有权
    适用于闪存的PCI Express兼容控制器和接口

    公开(公告)号:US20090049222A1

    公开(公告)日:2009-02-19

    申请号:US12254428

    申请日:2008-10-20

    IPC分类号: G06F13/00 G06F12/00

    摘要: A PCI Express-compatible flash device can include one or more flash memory modules, a controller, and an ExpressCard interface. The controller can advantageously provide PCI Express functionality as well as flash memory operations, e.g. writing, reading, or erasing, using the ExpressCard interface. A PIO interface includes sending first and second memory request packets to the flash device. The first memory request packet includes a command word setting that prepares the flash device for the desired operation. The second memory request packet triggers the operation and includes a data payload, if needed. A DMA interface includes sending the second memory request from the flash device to the host, thereby triggering the host to release the system bus for the DMA operation.

    摘要翻译: 兼容PCI Express的闪存设备可以包括一个或多个闪存模块,控制器和ExpressCard接口。 控制器可以有利地提供PCI Express功能以及闪速存储器操作,例如, 使用ExpressCard接口进行写入,读取或擦除。 PIO接口包括向闪存设备发送第一和第二存储器请求包。 第一存储器请求分组包括为所需操作准备闪存设备的命令字设置。 如果需要,第二存储器请求分组触发操作并且包括数据有效载荷。 DMA接口包括将第二存储器请求从闪存设备发送到主机,从而触发主机释放用于DMA操作的系统总线。

    Boot management in computer systems assisted by an endpoint with PCI-XP or USB-V2 interface
    9.
    发明授权
    Boot management in computer systems assisted by an endpoint with PCI-XP or USB-V2 interface 失效
    由PCI-XP或USB-V2接口的端点辅助的计算机系统启动管理

    公开(公告)号:US07299347B1

    公开(公告)日:2007-11-20

    申请号:US10817601

    申请日:2004-04-02

    申请人: I-pieng Peter Kao

    发明人: I-pieng Peter Kao

    IPC分类号: G06F15/177 G06F3/00

    CPC分类号: G06F9/4401

    摘要: An intelligent endpoint can provide an automated, centralized boot management for multiple, interconnected computer systems. The intelligent endpoint can be notified of a boot event for one of the computer systems. This notification can occur over a system bus or via a system fabric. The intelligent endpoint can then decide on an appropriate action for the boot event. Notably, the action may affect or depend on a boot of another computer system. The intelligent endpoint can advantageously resolve arbitration issues in a cost- and size-efficient manner. Moreover, the intelligent endpoint can provide significant flexibility during booting.

    摘要翻译: 智能端点可以为多个互连的计算机系统提供自动化的集中式引导管理。 智能端点可以被通知一个计算机系统的引导事件。 该通知可以通过系统总线或通过系统结构进行。 然后,智能端点可以决定引导事件的适当操作。 值得注意的是,该动作可能会影响或依赖于其他计算机系统的启动。 智能端点可以有利地以成本和尺寸有效的方式解决仲裁问题。 此外,智能端点可以在引导期间提供显着的灵活性。

    Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
    10.
    发明授权
    Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells 失效
    联合治疗二萜类三环氧化物和死亡域受体配体对肿瘤细胞的协同杀伤

    公开(公告)号:US06329148B1

    公开(公告)日:2001-12-11

    申请号:US09505250

    申请日:2000-02-15

    IPC分类号: C12Q168

    摘要: A synergistic combination of ligands that interact with death domain receptors, and diterpenoid triepoxides is used to increase tumor cell killing by induction of apoptosis. Ligands useful in the invention include TRAIL, TNF-&agr;, analogs thereof, stabilized multimers thereof, mimetics, etc. Of particular interest are combined therapy with the diterpenoid triepoxides triptolide and derivatives and analogs thereof.

    摘要翻译: 与死亡域受体相互作用的配体和二萜类三环氧化物的协同组合用于通过诱导凋亡来增加肿瘤细胞杀伤。 可用于本发明的配体包括TRAIL,TNF-α,其类似物,稳定的多聚体,模拟物等。特别令人感兴趣的是与二萜类三环氧化物雷公藤内酯及其衍生物和类似物的组合治疗。